title: [Rectal endocrine intermediate-cell carcinoma].
abstract: An 82-year-old patient complained of diarrhea due to a rectal endocrine intermediate-cell carcinoma. Histology displayed a neuron-specific enolase and CD56 immunoreactive tumor. Hepatic metastases developed rapidly and the tumor was briefly reactive to radiotherapy and chemotherapy. These tumors are rare and have a poor prognosis. We focus on the recent classification of gastrointestinal endocrine tumors.
authors.affiliation: Service de Clinique Médicale, Hospital du Val-de-Grace, Paris, Cedex, France. bechade.dominique@wanadoo.fr
authors.forename: Dominique
authors.initials: D
authors.lastname: Béchade
authors.forename: Jérôme
authors.initials: J
authors.lastname: Desramé
authors.forename: Olivier
authors.initials: O
authors.lastname: Berthelet
authors.forename: Stéphane
authors.initials: S
authors.lastname: Lecoules
authors.forename: Gilles
authors.initials: G
authors.lastname: Coutant
authors.forename: Michel
authors.initials: M
authors.lastname: Arborio
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Algayres
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019002:CD56 Antigen / Q000032:analysis; D003131:Combined Modality Therapy; D003967:Diarrhea / Q000209:etiology; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D011379:Prognosis; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy
chemical_list: D019002:CD56 Antigen